Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: An optical coherence tomography study

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages 259-267

  Räber, Lorenz ^a   Zanchin, Thomas ^a   Baumgartner, Sandro ^a   Taniwaki, Masanori ^a   Kalesan, Bindu ^b   Moschovitis, Aris ^a   Garcia Garcia, Hector M ^c   Justiz, Jörn ^d   Pilgrim, Thomas ^a   Wenaweser, Peter ^a   Meier, Bernhard ^a   Jüni, Peter ^b   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Human Centered Engineering Institute of Applied Sciences   (Switzerland)

Author keywords

Acute coronary syndrome; Arterial healing; Drug eluting stent; Optical coherence tomography

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTRUDING STENT STRUT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT EVAGINATION; STENT MALAPPOSITION; UNCOVERED STENT STRUT; WOUND HEALING; AGED; CORONARY BLOOD VESSEL; MIDDLE AGED; PATHOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

IMMUNOSUPPRESSIVE AGENT; PACLITAXEL; RAPAMYCIN; TUBULIN MODULATOR;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUBULIN MODULATORS; WOUND HEALING;

EID: 84898882729     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.02.036     Document Type: Article

References (25)

1. G. Nakazawa, A.V. Finn, and M. Joner et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
2. N. Gonzalo, P. Barlis, and P.W. Serruys et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography JACC Cardiovasc Interv 2 2009 445 452
3. T. Kubo, T. Imanishi, and H. Kitabata et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study JACC Cardiovasc Imaging 1 2008 475 484
4. M. Takano, S. Inami, and I.K. Jang et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
5. G. Guagliumi, V. Sirbu, and G. Musumeci et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging JACC Cardiovasc Interv 5 2012 12 20
6. L. Raber, L. Wohlwend, and M. Wigger et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial Circulation 123 2011 2819 2828
7. L. Raber, S. Baumgartner, and H.M. Garcia et al. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study JACC Cardiovasc Interv 5 2012 946 957
8. S. Cook, P. Eshtehardi, and B. Kalesan et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation Eur Heart J 33 2012 1334 1343
9. M.D. Radu, L. Raber, and B. Kalesan et al. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study Eur Heart J 2013 10.1093/eurheartj/eht344
10. T. Kubo, T. Imanishi, and S. Takarada et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy J Am Coll Cardiol 50 2007 933 939
11. S. Cook, P. Wenaweser, and M. Togni et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434
12. F. Alfonso, M.J. Perez-Vizcayno, and M. Ruiz et al. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings J Am Coll Cardiol 53 2009 2053 2060
13. J. Narula, M. Nakano, and R. Virmani et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques J Am Coll Cardiol 61 2013 1041 1051
14. A.D.V.N. Levin, C.W. Hwang, and E.R. Edelman Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel Proc Natl Acad Sci U S A 101 2004 9436 9467
15. C.W. Hwang, A.D. Levin, M. Jonas, P.H. Li, and E.R. Edelman Thrombosis modulates arterial drug distribution for drug-eluting stents Circulation 111 2005 1619 1626
16. Y.J. Hong, M.H. Jeong, and Y.H. Choi et al. Relation between poststenting peristent plaque components and late stent malapposition after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysis Int J Cardiol 167 2012 1848 1853
17. K. Xu, G.S. Mintz, and T. Kubo et al. Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial Circ Cardiovasc Interv 5 2012 185 192
18. Y. Ozaki, M. Okumura, and T.F. Ismail et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study Eur Heart J 31 2010 1470 1476
19. H. Kawamori, J. Shite, and T. Shinke et al. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-t.erm follow-up Eur Heart J Cardiovasc Imaging 14 2013 865 875
20. P. Wenaweser, J. Daemen, and M. Zwahlen et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-Year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
21. G. Leibundgut, F. Nietlispach, U. Pittl, H. Brunner-La Rocca, C.A. Kaiser, and M.E. Pfisterer Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina - comparison of the effects of drug-eluting versus bare-metal stents Am Heart J 158 2009 271 276
22. G.D. Dangas, A. Caixeta, and R. Mehran et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
23. G.W. Stone, A. Rizvi, and K. Sudhir et al. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-Year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
24. G. Sianos, M.I. Papafaklis, and J. Daemen et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden J Am Coll Cardiol 50 2007 573 583
25. J.L. Gutierrez-Chico, J. Wykrzykowska, and E. Nuesch et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography Circ Cardiovasc Interv 5 2012 20 29